A comparison of economic aspects of hospitalization versus ambulatory care in the management of neuritis occurring in lepra reaction

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 72, Issue 4, 2004, Pages 448-456

  Ravi, H N ^a   George, Renu ^a   Eapen, Elizabeth P ^a   Pulimood, Susanne A ^a   Gnanamuthu, Chandran ^a   Jacob, Mary ^a   John, K R ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; GENERAL CONDITION IMPROVEMENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LEPROSY; MOTOR PERFORMANCE; NEURITIS; PERIPHERAL NERVOUS SYSTEM FUNCTION; QUALITY OF LIFE; SENSORIMOTOR FUNCTION; SENSORY EVALUATION; TREATMENT OUTCOME; WORK RESUMPTION;

ADOLESCENT; ADULT; AMBULATORY CARE; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LEPROSY; MALE; MIDDLE AGED; NEURITIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 13144249128     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: 10.1489/1544-581X(2004)72<448:ACOEAO>2.0.CO;2     Document Type: Article

References (13)

1. ANONYMOUS. How to Read Journals VII. To understand an economic evaluation (Part A). Clinical epidemiology rounds. Can. Med. Assoc. J. 130 (1984) 1428-1434.
2. ANONYMOUS. How to read journals VII. To understand an economic evaluation. (Part B). Clinical epidemiology rounds. Can. Med. Assoc. J. 130 (1984) 1542-1549.
3. BECX-BLEUMINK, M., and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multi drug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabiliation Training Center (ALERT) in Ethiopia. Int. J. Lepr. Other Mycobact. Dis. 60(2) (1992) 173-184.
4. CROFT, R. P., NICHOLLS, P. G., RICHARDUS, J. H., and SMITH, C. W. S. Treatment of acute nerve formation in leprosy results from a prospective cohort study in Bangladesh. Lepr. Rev. 71(2) (2000) 154-168.
5. GEETHA, A. J., and SUNDAR RAO, O. PSS. Impact of leprosy on the quality of life. Bull. WHO 77(6) (1999) 515-517.
6. KIRAN, K. U., STANLEY, J. N. A., and PEARSON, J. M. H. The outpatient treatment of nerve damage in patients with borderline leprosy using a semi-standardized steroid regimen. Lepr. Rev. 56 (1985) 127-134.
7. KOPPARTY, S. N. M. Problems, acceptance, and social inequality: a study of the deformed leprosy patients and their families. Lepr. Rev. 66 (1995) 239-249.
8. LOCKWOOD, D. N. J. Steroids in leprosy type 1 (reversal) reactions: mechanism of action and effectiveness. Workshop proceedings. Lepr. Rev. 71(suppl) (2000) 111-114.
9. NAIK, S. S, and GANAPATI, R. Socioeconomics of a global leprosy eradication program. Pharmacoeconomics 13(6) (1998) 677-686.
10. RAO, V. P., RAO, I. R., and PALANDE, D. D. Socioeconomic rehabilitation programs of LEPRA India-methodology, results and application of needs-based socio-economic evaluation. Lepr. Rev. 71 (2000) 466-471.
11. SCOTT, J. The psychosocial needs of leprosy patients. Lepr. Rev. 71 (2000) 486-491.
12. VAN BRAKEL, W. H. Current issues in nerve function assessment and interpretation of NFA results. Proceedings of the TLM South-Asia superintendents POD workshop. Kathmandu, Nepal. February 13-16 (1998).
13. THE WHO-QOL GROUP. People and health. What quality of life? World Health Forum. 17 (1996) 354-357.